🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT06475053
Active, not recruiting Not applicable

Visual Performance of Center Distance Daily Disposable Multifocal Lenses

NCT06475053 · tracked via the Priya Life Science USA tracker
Sponsor
Visioneering Technologies, Inc
Phase
Not applicable
Started
2024-07-31
Last updated
2025-09-22

Condition(s) studied

Myopia

Investigational drug(s) / intervention(s)

NaturalVue Enhanced Multifocal 1 Day contact lensMiSight 1 Day contact lens

NaturalVue Enhanced Multifocal 1 Day contact lens: Daily disposable multifocal contact lens

MiSight 1 Day contact lens: Daily disposable dual-focus contact lens

Study summary

The purpose of this study is to compare visual performance (high and low contrast acuity, reading acuity, contrast sensitivity, stereoacuity, accommodative response, eye hand coordination, far near vision, and dynamic vision) between Visioneering Technologies, Inc. NaturalVue Multifocal and CooperVivion MiSight.

Eligibility

Sex
ALL
Min age
9 Years
Max age
30 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Participants must satisfy the following conditions for inclusion in the trial: * Be between 9 and 30 years of age * Sign written Informed Consent/Assent. * Spherical Equivalent glasses prescription: -0.50 to -7.00 diopters (D), Astigmatism: ≤ -0.75D, Anisometropia: ≤ 1.00D * 20/20 vision in each eye * Existing contact lens wearer * An eye exam in last 9 months, normal stereoacuity on prior chart (or test if not available) * No known ocular disease - anterior or posterior (posterior determined by history/chart) * Have an acceptable or optimal fit with test lenses and be willing to wear these lenses as directed for the duration of the study. * On examination, have ocular findings considered to be within normal limits. * Be willing and able to follow instructions and attend the schedule of follow-up visits. Exclusion Criteria: * Any of the following will exclude a participant from this trial: * Current hard lens wearers * Using eye medication contraindicating lens wear such as daily use of artificial tears. * Eye injury or surgery within twelve weeks immediately prior to enrollment for this trial. * History of corneal refractive surgery * Currently enrolled in an ophthalmic clinical trial that could negatively impact corneal or conjunctival health in this trial. * Evidence of systemic or ocular abnormality, infection or disease likely to affect successful wear of contact lenses or use of their accessory solutions. * Allergy or sensitivity to any product used in this trial. * Pre-existing ocular condition that would contraindicate lens wear. * Any systemic disease including autoimmune disease, immunocompromising diseases, connective tissue disease, clinically significant atopic diseases, insulin dependent diabetes, use of medications including corticosteroids and antimetabolites that may affect the eye or be exaggerated by wearing contact lenses. * Lazy eye (Strabismus or amblyopia) * Pupil size \< 3.00 mm in either eye in dim light (measured at approximately 10 cd/m2 )

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
The Ohio State University College of Optometry Columbus Ohio

More Visioneering Technologies, Inc trials in the USA

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06475053 on ClinicalTrials.gov ↗ ← All trials in the USA